Oxygen nanobubbles
Oxygen nanobubbles has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Feb 10, 2026: “Nanobubble-Mediated Oxygen Delivery Mitigates Hypoxia-Induced ROS and HIF-1α Expression in UC-MSCs”.
1 paper studies it3 findingsUpdated
See all 1 papers on oxygen nanobubbles
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Agencia Nacional de Investigación y Desarrollo and 1 more
- Cells1
What did studies of oxygen nanobubbles find?
3Studies of oxygen nanobubbles measured 3 outcomes: HIF1A, oxidative stress and ROS signaling and cell viability.
HIF1A
downin human cells1
1 study
HIF1A
downin human cells1
Oxygen nanobubbles decrease HIF1A in human cells (~8-9 fold).
Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS) relative to untreated hypoxic controls
Oxidative stress and ROS signaling
downin human cells1−20%
1 study
Oxidative stress and ROS signaling
downin human cells1−20%
Oxygen nanobubbles decrease oxidative stress and ROS signaling in human cells under hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS) (~20%).
Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS)
Cell viability
upin human cells1
1 study
Cell viability
upin human cells1
Oxygen nanobubbles improve cell viability in human cells under hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS).
Cellsunder hypoxic stress (2D ischemia-mimetic model: 1% O2 and 1% FBS)